Riskpilot← Back to searchSign inGet full accessMariaMedical Oy
OYActiveY-tunnus 3149993-2Proomukatu 18-14Veterinary activities · NACE 7500Est. 2020— employees
Revenue 2024
EUR 1,1M
+53% vs 2023
EBITDA margin
185.5%
+51% vs 2023
Equity ratio
62.3%
Financial strength
Net profit 2024
EUR 116K
+97% vs 2023
| Revenue | EUR 1,1M | +53% |
| EBITDA | EUR 2M | +51% |
| Net profit | EUR 116K | +97% |
| Total assets | EUR 422K | +73% |
| Equity | EUR 263K | +64% |
| Employees | — | — |
Legal name
MariaMedical Oy
Y-tunnus number
3149993-2
Legal form
Osakeyhtiö
NACE code
7500 · Veterinary activities
Founded
30. heinäkuuta 2020
Share capital
EUR 30 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on eläinlääkintäpalvelut.
Address
Proomukatu 18-14
Phone
+358440303825
Email
janne_vaattovaara@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 425 | 522 | 721 | 1 105 |
| Staff expenses | −121 | 209 | 237 | 344 |
| EBITDA | 90 | 987 | 1 356 | 2 050 |
| Depreciation & amort. | −10 | 14 | 12 | 15 |
| EBIT | 80 | 42 | 74 | 145 |
| Net financials | — | −0 | — | — |
| Profit before tax | 80 | 42 | 73 | 145 |
| Tax | 16 | 6 | 15 | 29 |
| Net profit | 64 | 36 | 59 | 116 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 173 | 185 | 245 | 422 |
| Equity | 80 | 110 | 160 | 263 |
| Long-term debt | — | — | — | — |
| Short-term debt | 93 | 75 | 85 | 159 |
| Total debt | 93 | 75 | 85 | 159 |
EBITDA margin
185.5%
This company
15.8%
Market median
+1074% vs market
20212024
Equity ratio
62.3%
This company
38.2%
Market median
+63% vs market
20212024
Return on equity
44.0%
This company
18.4%
Market median
+139% vs market
20212024
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
20212024
Asset turnover
2.62×
This company
1.12×
Market median
+134% vs market
20212024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20212024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
LI | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairperson | 2025 | |
| Former (2) | ||
| Chairperson | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MariaMedical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Maria Sillanpää | Chief Executive Officer | 0 companies |
| Laura Ida Emilia Tuomi | Audit | 0 companies |
| Olli Artturi Leikkonen | Board of Directors | 0 companies |
| Juho Mikael Nirkkonen | Board of Directors | 0 companies |
| Janne Tapani Vaattovaara | Chairperson | 0 companies |
| Juhani Matti Sillanpää | Board of Directors | 0 companies |
| Risto Sakari Kankaanpää | Chairperson | 0 companies |